Dacarbazine and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Dacarbazine (dacarbazine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vinblastine Sulfate, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Itching when taking Dacarbazine. It is created by eHealthMe based on reports of 8,052 people who have side effects when taking Dacarbazine from the FDA, and is updated regularly.

What is Dacarbazine?

Dacarbazine has active ingredients of dacarbazine. eHealthMe is studying from 8,064 Dacarbazine users. Check the latest studies of Dacarbazine.

What is Itching?

Itching is found to be associated with 3,209 drugs and 4,533 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 10, 2026

8,052 people reported to have side effects when taking Dacarbazine.
Among them, 48 people (0.6%) have Itching.

Among these 48 people:

How long have people been on Dacarbazine when they have Itching? *

What is the gender of people who have Itching when taking Dacarbazine? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Itching when taking Dacarbazine? *

What are other drugs people take besides Dacarbazine? *

Vinblastine Sulfate: 11 people, 22.92%
Bleomycin Sulfate: 10 people, 20.83%
Dexilant: 5 people, 10.42%
Vinorelbine: 5 people, 10.42%
Doxorubicin Hydrochloride: 5 people, 10.42%
Neulasta: 5 people, 10.42%
Methotrexate: 4 people, 8.33%
Prednisone: 4 people, 8.33%
Lasix: 3 people, 6.25%
Inflectra: 3 people, 6.25%

What are other side effects people have besides Itching? *

Nausea (feeling of having an urge to vomit): 16 people, 33.33%
Rashes (redness): 15 people, 31.25%
Fever: 14 people, 29.17%
Diarrhea: 13 people, 27.08%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 13 people, 27.08%
Thrombocytopenia (decrease of platelets in blood): 10 people, 20.83%
Nausea And Vomiting: 10 people, 20.83%
Drug Ineffective: 9 people, 18.75%
Anaemia (lack of blood): 8 people, 16.67%
Aspartate Aminotransferase Increased: 7 people, 14.58%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 16 people, 33.33%
Malignant Melanoma (skin cancer rises from melancytes): 5 people, 10.42%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 10.42%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 6.25%
Hiv Infection: 2 people, 4.17%
Lymphoma (cancer that begins in immune system cells): 1 person, 2.08%
Colitis (inflammation of colon): 1 person, 2.08%
High Blood Cholesterol: 1 person, 2.08%
High Blood Pressure: 1 person, 2.08%
Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 1 person, 2.08%

* Approximation only. Some reports may have incomplete information.

Do you take Dacarbazine and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dacarbazine:

Dacarbazine (8,064 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Dacarbazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,209 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,533 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dacarbazine (the active ingredients of Dacarbazine) and Dacarbazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.